Why the Ecofibre (ASX:EOF) share price is surging 30% higher this week

The hemp company's shares have been on fire lately…

| More on:
A drawing of a rocket follows a chart up, indicating share price lift

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ecofibre Ltd (ASX: EOF) share price has continued its impressive run today following an interim sales update.

During early afternoon trade, the hemp company's shares are fetching for $1.15, up 6.98%. This brings Ecofibre shares to a gain of around 30% over the last 4 trading days.

How is Ecofibre performing?

Investors are snapping up Ecofibre shares in light of the company's impressive sales figures for its Ananda Professional business.

Ecofibre's Ananda Health division is the number one provider of hemp-derived CBD for retail pharmacies in the United States. The business produces nutraceutical products, topical creams and ointments. There is even a CBD oil specifically for pets such as dogs and cats.

In its announcement, Ecofibre advised that its Ananda Professional CBD products have recorded their highest revenues since September 2020. The strong result has seen the business achieved sales of around $800,000 for the month of May. September 2020 sales attained roughly $900,000.

Management noted that while the sales rebound is positive, monthly results may fluctuate in the short term.

Ecofibre CEO, Eric Wang touched on the company's progress saying:

This result reflects a combination of trading conditions improving in our core independent pharmacy channel, ongoing investment in new products and direct engagement to support our pharmacy partners.

As we enter a post-COVID environment, we are beginning to see many of our pharmacy partners begin to return to normal operations. Whilst there is still a lot of focus on COVID related activities such as vaccines, it is pleasing to see signs of recovery in our core channel.

Additionally, sales of the new Ananda Professional Chewable products and Women's Health range have been encouraging. We also launched Ananda Professional's new direct-to- consumer e-commerce portal with 70 pharmacies in early May, and the business is now focused on building momentum through positive early-adopter experiences.

Ecofibre share price snapshot

While today's update has lifted Ecofibre shares even further, yearly share price performance has not been so kind to investors. The company's share price has fallen more than 50% from the past 12 months and is down almost 40% year-to-date.

Ecofibre has a market capitalisation of approximately $397 million, with approximately 341 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

Health professional working on his laptop.
Healthcare Shares

NIB shares edge higher on profit update

Let's see why this private health insurer is in the news today.

Read more »

Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.
Healthcare Shares

Bell Potter names the best ASX healthcare shares to buy in 2026

Healthy returns could be on offer with these shares according to the broker.

Read more »

man cupping ear as if to listen closely, rumour, cochlear
Healthcare Shares

Why is everyone talking about Telix shares this week?

Let's see why this biotech stock has been on the move this week.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »

ecommerce asx shares represented by santa doing online shopping on laptop
Healthcare Shares

Looking for ideas before Christmas? These 2 ASX shares stand out to me

Two ASX shares at opposite ends of the market are catching my attention as the year draws to a close.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »